Results 61 to 70 of about 17,001 (224)

Current Trends of Lassa fever amidst COVID-19 Pandemic in Nigeria

Global Biosecurity, 2023
Lassa fever is a disease endemic in West Africa caused by the Lassa virus (LASV). The emergence of the COVID-19 pandemic has put an extra burden on Nigeria in the fight against infectious disease outbreaks.
Jeremiah Oluwamayowa Omojuyigbe, Habeebullah Jayeola Oladipo, Moriam Adesola Adegbite, Yusuf Babatunde, Taiwo Oluwaseun Sokunbi, Oluwakorede Adedeji, Ibrahim Abdulmumin   +6 more
doaj   +1 more source

From Lake Victoria to the Tap: Antibiotic Resistance and Pathogenic Contamination of Kisumu City Water Supply and Wastewater Network

Tropical Medicine &International Health, Volume 31, Issue 4, Page 547-559, April 2026.
ABSTRACT Waterborne diseases and antimicrobial resistance (AMR) pose mounting public health threats across sub‐Saharan Africa, particularly in rapidly urbanising regions dependent on untreated or poorly treated surface waters. This study applied shotgun metagenomic sequencing to characterise microbial communities, virulence factors and antibiotic ...
Oleg N. Reva, Anthony Sifuna, Francis Orata, Caroline Omolo, Jacob Stanley Iramiot, Mark C. Enright, Awelani Mutshembele, Jian Zhou, William A. Shivoga   +8 more
wiley   +1 more source

Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses.

PLoS Pathogens, 2017
Cell entry of many enveloped viruses occurs by engagement with cellular receptors, followed by internalization into endocytic compartments and pH-induced membrane fusion.
Hadar Israeli, Hadas Cohen-Dvashi, Anastasiya Shulman, Amir Shimon, Ron Diskin   +4 more
doaj   +1 more source

High crossreactivity of human T cell responses between Lassa virus lineages.

PLoS Pathogens, 2020
Lassa virus infects hundreds of thousands of people each year across rural West Africa, resulting in a high number of cases of Lassa fever (LF), a febrile disease associated with high morbidity and significant mortality.
Brian M Sullivan, Saori Sakabe, Jessica N Hartnett, Nhi Ngo, Augustine Goba, Mambu Momoh, John Demby Sandi, Lansana Kanneh, Beatrice Cubitt, Selma D Garcia, Brian C Ware, Dylan Kotliar, Refugio Robles-Sikisaka, Karthik Gangavarapu, Luis Branco, Philomena Eromon, Ikponmwosa Odia, Ephraim Ogbaini-Emovon, Onikepe Folarin, Sylvanus Okogbenin, Peter O Okokhere, Christian Happi, Juan Carlos de la Torre, Pardis C Sabeti, Kristian G Andersen, Robert F Garry, Donald S Grant, John S Schieffelin, Michael B A Oldstone   +28 more
doaj   +1 more source

Fractional Order Epidemic System of Saturated Rate of Incidence: A Neural Network Approach

Engineering Reports, Volume 8, Issue 3, March 2026.
The workflow depictions of the mathematical fractional order saturated rate of incidence model using the process of Levenberg–Marquardt Backpropagation neural network. The designed neural network contains 20 numbers of neurons, a sigmoid activation function, and a single hidden layer structure.
Zulqurnain Sabir, M. A. Abdelkawy, Muhammad Umar, Soheil Salahshour   +3 more
wiley   +1 more source

Lassa Virus in Pygmy Mice, Benin, 2016–2017

Emerging Infectious Diseases, 2019
Lassa virus has been identified in 3 pygmy mice, Mus baoulei, in central Benin. The glycoprotein and nucleoprotein sequences cluster with the Togo strain. These mice may be a new reservoir for Lassa virus in Ghana, Togo, and Benin.
Anges Yadouleton, Achaz Agolinou, Fodé Kourouma, Raoul Saizonou, Meike Pahlmann, Sonia Kossou Bedié, Honoré Bankolé, Beate Becker-Ziaja, Fernand Gbaguidi, Anke Thielebein, N’Faly Magassouba, Sophie Duraffour, Jean-Pierre Baptiste, Stephan Günther, Elisabeth Fichet-Calvet   +14 more
doaj   +1 more source

Review of candidate vaccines for the prevention of Lassa fever

Вопросы вирусологии, 2021
The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1].
O. D. Popova, O. V. Zubkova, T. A. Ozharovskaia, D. I. Zrelkin, D. V. Voronina, I. V. Dolzhikova, D. V. Shcheblyakov, B. S. Naroditsky, D. Yu. Logunov, A. L. Gintsburg   +9 more
doaj   +1 more source

Molecular identification of adenoviruses associated with respiratory infection in Egypt from 2003 to 2010. [PDF]

, 2014
BACKGROUND: Human adenoviruses of species B, C, and E (HAdV-B, -C, -E) are frequent causative agents of acute respiratory infections worldwide. As part of a surveillance program aimed at identifying the etiology of influenza-like illness (ILI) in Egypt ...
A Kandeel, AC Kroes, Adriana Kajon, AE Kajon, AE Kajon, AH Kamel, AK Adhikary, Amany Elgohary Sheta, Amel Mohamed Nageib Hasanin, Anne M Gaynor, B Biere, B Cao, B Chmielewicz, B Lin, BDJ Hess, CD Brandt, Claire Cornelius, CT Garnett, D Metzgar, D Metzgar, G Wadell, GC Gray, GJ Vora, H Schmitz, HA El-Mahallawy, HG Pereira, HS Houng, I Luksic, J Abd-Jamil, JP Fox, JY Hong, Katherine C Horton, KL Russell, LK Crawford-Miksza, M El Sayed Zaki, M El-Sayed Zaki, MA Ryan, MKA Deming, OA Adeyemi, OA Adeyi, Pola N Demian, R Al-Toum, Rania Siam, RJ Cooper, S Alharbi, S Levin, SK Schepetiuk, SY Ou, T Kojaoghlanian, TE-MB El-Shewy, TT Pham, W Saitoh-Inagawa, W Xu, W Xu, WA Andiman, WC Russell, Y Chu, YJ Kim   +57 more
core   +1 more source

The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa, Agness Shimilimo, Olivier Uwishema, Helen Onyeaka   +3 more
wiley   +1 more source

Improving the Breadth of the Host’s Immune Response to Lassa Virus

Pathogens, 2018
In 2017, the global Coalition for Epidemic Preparedness (CEPI) declared Lassa virus disease to be one of the world’s foremost biothreats. In January 2018, World Health Organization experts met to address the Lassa biothreat.
Juan Carlos Zapata, Sandra Medina-Moreno, Camila Guzmán-Cardozo, Maria S. Salvato   +3 more
doaj   +1 more source